[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-112-2-medical-surgical-011":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-112-2-內外科護理學-011","nurse-112-2-medical-surgical-011",112,2,11,"有關消化性潰瘍的治療藥物，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"制酸劑","前列腺素合成劑","質子幫浦抑制劑","第一型組織胺接受器拮抗劑","D",null,[],"本題考點是消化性潰瘍的治療藥物分類，錯誤敘述為 D。依治療消化性潰瘍的藥理，抑制胃酸與保護黏膜是主軸：A 制酸劑中和已分泌的胃酸，正確；B 前列腺素合成劑（如 misoprostol）可抑制胃酸分泌並促進黏膜黏液與碳酸氫鹽分泌、保護黏膜，正確；C 質子幫浦抑制劑（PPI，如 omeprazole）阻斷胃壁細胞 H⁺\u002FK⁺-ATPase，是抑酸最強的藥物，正確。D 敘述錯誤：治療潰瘍用的是「第二型」組織胺接受器拮抗劑（H₂ blocker，如 cimetidine、ranitidine），作用於胃壁細胞的 H₂ 受體以減少胃酸；而「第一型（H₁）」拮抗劑是抗組織胺抗過敏藥物，與胃酸分泌無關，故此敘述錯誤而為答案。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840781549]